Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-23T13:32:21.569Z Has data issue: false hasContentIssue false
  • English
  • Français

Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin

Published online by Cambridge University Press:  18 February 2010

Anneli G. Olsson ,
Inga Markhede ,
Susann Strang  and
Lennart I. Persson
Anneli G. Olsson*
Affiliation:
Department of Neurology, Institute of Clinical Neuroscience and Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Göteborg, Sweden
Inga Markhede
Affiliation:
Department of Neurology, Institute of Clinical Neuroscience and Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Göteborg, Sweden
Susann Strang
Affiliation:
Department of Neurology, Institute of Clinical Neuroscience and Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Göteborg, Sweden
Lennart I. Persson
Affiliation:
Department of Neurology, Institute of Clinical Neuroscience and Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Göteborg, Sweden
*
Address correspondence and reprint requests to: Anneli G. Olsson, Department of Neurology, Sahlgrenska University Hospital, S 413 45 Göteborg, Sweden. E-mail: anneli.g.olsson@vgregion.se
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The aim of this study was to examine health-related quality of life (HRQoL), individual QoL, anxiety and depression in patients with amyotrophic lateral sclerosis (ALS) and their next of kin in relation to patients' physical function over time.

Methods:

35 patients and their next of kin were studied using the Short Form-36 Health Survey (SF-36), Schedule for Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW), and Hospital Anxiety and Depression Scale (HADS) and patients also by the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised and the Norris scale every fourth to sixth month, one to four times.

Results:

Changes were found over time in both patients and their next of kin in the SF-36 but not in the SEIQoL-DW or HADS. Patients rated worse than their next of kin in the SF-36 physical subscales and next of kin rated worse than the patients in the global QoL score in SEIQoL-DW. Health, hobbies, and total relations were important areas in the SEIQoL-DW among all participants, but some important areas also differed between the patients and their next of kin. In most important areas among the pairs, the next of kin estimated their functioning/satisfaction worse than patients estimated their functioning/satisfaction.

Significance of results:

There were few changes over time in the QoL among the participants. Although most of the estimates in patients and their next of kin were equal, there were also some differences. These results emphasize the importance of support for both patients and their next of kin and that support ought to be given on both individual bases and together in pairs. The SEIQoL-DW might give signposts in the care through the course of the disease about what should be focused on to increase satisfaction of the important areas of life and might help the person to find coping strategies to handle his or her life situation.

Keywords

ALSAnxietyCaregiverNext of kinQuality of life
Type
Original Articles
Information
Palliative & Supportive Care , Volume 8 , Issue 1 , March 2010 , pp. 75 - 82
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Bromberg, M.B. & Forshew, D.A. (2002). Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology, 58, 320–322.CrossRefGoogle ScholarPubMed
Brooks, B.R. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 124(Suppl), 96–107.CrossRefGoogle Scholar
Bungener, C., Piquard, A., Pradat, P.F., et al. (2005). Psychopathology in amyotrophic lateral sclerosis: A preliminary study with 27 ALS patients. Amyotrophic Lateral Sclerosis, 6, 221–225.CrossRefGoogle ScholarPubMed
Cedarbaum, J.M., Stambler, N., Malta, E., et al. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences, 169, 13–21.CrossRefGoogle ScholarPubMed
Chio, A., Gauthier, A., Calvo, A., et al. (2005). Caregiver burden and patients' perception of being a burden in ALS. Neurology, 64, 1780–1782.CrossRefGoogle ScholarPubMed
Chio, A., Gauthier, A., Montuschi, A., et al. (2004). A cross sectional study on determinants of quality of life in ALS. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1597–1601.CrossRefGoogle ScholarPubMed
De Groot, I.J., Post, M.W., van Heuveln, T., et al. (2007). Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 8, 356–361.CrossRefGoogle ScholarPubMed
Felgoise, S.H., Stewart, J.L., Bremer, B.A., et al. (2009). The SEIQoL-DW for assessing quality of life in ALS: Strengths and limitations. Amyotrophic Lateral Sclerosis, 10, 456–462.CrossRefGoogle ScholarPubMed
Forbes, R.B., Colville, S., Cran, G.W., et al. (2004). Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1753–1755.CrossRefGoogle ScholarPubMed
Gauthier, A., Vignola, A., Calvo, A., et al. (2007). A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology, 68, 923–926.CrossRefGoogle ScholarPubMed
Goldstein, L.H., Atkins, L., Landau, S., et al. (2006). Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: A longitudinal study. Psychological Medicine, 36, 865–875.CrossRefGoogle ScholarPubMed
Hickey, A.M., Bury, G., O'Boyle, C.A., et al. (1996). A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. British Medical Journal, 313, 29–33.CrossRefGoogle Scholar
Krampe, H., Bartels, C., Victorson, D., et al. (2008). The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotrophic Lateral Sclerosis, 9, 99–107.CrossRefGoogle ScholarPubMed
Lo Coco, G., Lo Coco, D., Cicero, V., et al. (2005). Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers. Journal of the Neurological Sciences, 238, 11–17.CrossRefGoogle ScholarPubMed
Myers, B.A. (1987). The Mini Mental State in those with developmental disabilities. Journal of Nervous and Mental Disease, 175, 85–89.CrossRefGoogle Scholar
Neudert, C., Oliver, D., Wasner, M., et al. (2001 a). The course of the terminal phase in patients with amyotrophic lateral sclerosis. Journal of Neurology, 248, 612–616.CrossRefGoogle ScholarPubMed
Neudert, C., Wasner, M., & Borasio, G.D. (2001 b). Patients' assessment of quality of life instruments: A randomized study of SIP, SF-36, and SEIQoL-DW in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191, 103–109.CrossRefGoogle ScholarPubMed
Neudert, C., Wasner, M., & Borasio, G.D. (2004). Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. Journal of Palliative Medicine, 7, 551–557.CrossRefGoogle ScholarPubMed
Nolan, M.T., Kub, J., Hughes, M.T., et al. (2008). Family health care decision making and self-efficacy with patients with ALS at the end of life. Palliative & Supportive Care, 6, 273–280.CrossRefGoogle ScholarPubMed
Norquist, J.M., Jenkinson, C., Fitzpatrick, R., et al. (2003). Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time. Amyotrophic Lateral Sclerosis, 4, 112–117.CrossRefGoogle ScholarPubMed
Norris, F.H. Jr., Calanchini, P.R., Fallat, R.J., et al. (1974). The administration of guanidine in amyotrophic lateral sclerosis. Neurology, 24, 721–728.CrossRefGoogle ScholarPubMed
Olsson, A.G., Markhede, I., Strang, S., et al. (in press). Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time. Acta Neurologica Scandinavica.Google Scholar
Persson, L.O., Karlsson, J., Bengtsson, C., et al. (1998). The Swedish SF-36 Health Survey II. Evaluation of clinical validity: Results from population studies of elderly and women in Gothenborg. Journal of Clinical Epidemiology, 51, 1095–1103.Google Scholar
Rabkin, J.G., Albert, S.M., Del Bene, M.L., et al. (2005). Prevalence of depressive disorders and change over time in late-stage ALS. Neurology, 65, 62–67.CrossRefGoogle ScholarPubMed
Sullivan, M. & Karlsson, J. (1998). The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: Results from normative population. Journal of Clinical Epidemiology, 51, 1105–1113.Google Scholar
Sullivan, M., Karlsson, J., & Ware, J.E. Jr. (1995). The Swedish SF-36 Health Survey—I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Social Science and Medicine, 41, 1349–1358.CrossRefGoogle ScholarPubMed
Trail, M., Nelson, N.D., Van, J.N., et al. (2003). A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. Journal of the Neurological Sciences, 209, 79–85.CrossRefGoogle ScholarPubMed
Vignola, A., Guzzo, A., Calvo, A., et al. (2008). Anxiety undermines quality of life in ALS patients and caregivers. European Journal of Neurology, 15, 1231–1236.CrossRefGoogle ScholarPubMed
Wicks, P., Abrahams, S., Masi, D., et al. (2007). Prevalence of depression in a 12-month consecutive sample of patients with ALS. European Journal of Neurology, 14, 993–1001.CrossRefGoogle Scholar
Winhammar, J.M., Rowe, D.B., Henderson, R.D., et al. (2005). Assessment of disease progression in motor neuron disease. Lancet Neurology, 4, 229–238.CrossRefGoogle ScholarPubMed
Worms, P.M. (2001). The epidemiology of motor neuron diseases: A review of recent studies. Journal of the Neurological Sciences, 191, 3–9.CrossRefGoogle ScholarPubMed
Zigmond, A.S. & Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.CrossRefGoogle ScholarPubMed